Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis

Male 0301 basic medicine 570 Science Immunology 610 Enzyme-Linked Immunosorbent Assay Cross Reactions FOS: Health sciences Microbiology 03 medical and health sciences Bacterial Proteins Latent Tuberculosis Virology Health Sciences Pathology Humans Tuberculosis alpha-Crystallins Biology Antibody Immunology and Microbiology Antigens, Bacterial Latent tuberculosis FOS: Clinical medicine Q R Gastrointestinal Viral Infections and Vaccines Development Life Sciences Mycobacterium tuberculosis Leptospirosis: Zoonotic Disease and Global Impact 3. Good health Infectious Diseases Immunoglobulin M Immunoglobulin G FOS: Biological sciences Medicine QR Microbiología Female Parasitology Research Article
DOI: 10.1371/journal.pone.0181714 Publication Date: 2017-08-16T19:15:19Z
ABSTRACT
Mycobacterium tuberculosis is a pathogen causing (TB) spectrum of disease including acute and asymptomatic latent stages. Identifying treating latently-infected patients constitutes one the most important impediments to TB control efforts. Those individuals can remain undiagnosed for decades serving as potential reservoirs reactivation. Tests accurate diagnosis infection currently are unavailable. HspX protein (α-crystallin), encoded by Rv2031c gene, produced in vitro M. during stationary growth phase hypoxic or acidic culture conditions. In this study, using standard, Luminex xMAP® bead capture ELISA, respectively, we report on detection anti-HspX IgG IgM antibodies sera from patients. For antibody screen, levels were similar between non-infected active patients; however, classified into group with showed higher values (p = 0.003) compared Using antigen assay, was detected 56.5% putative cases (p< 0.050) background median an average 9,900 pg/ml range 1,000 36,000 pg/ml. Thus, presence may be markers TB.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (24)